Emergence of CD52^-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment
スポンサーリンク
概要
著者
-
Tite John
Molecular Immunology Group Wellcome Research Laboratories
-
Brett Sara
Molecular Immunology Group Wellcome Research Laboratories
-
Rowan Wendy
Molecular Immunology Group Wellcome Research Laboratories
-
BAXTER Gillian
Molecular Immunology Group Wellcome Research Laboratories
-
COOPER Helen
Molecular Immunology Group Wellcome Research Laboratories
-
REGAN Tessa
Clinical Oncology Group Wellcome Research Laboratories
-
RAPSON Nick
Molecular Immunology Group Wellcome Research Laboratories
関連論文
- Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes
- Emergence of CD52^-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment